Sector: Chemicals

Latest content

Six life sciences IP dealmaking trends to watch out for in 2021

Despite a turbulent 2020 for pharma transactions, it is possible to discern a few patterns for activity in the market this year

19 January 2021

New Brazilian biotech patent examination guidelines a “missed opportunity”

While boosting transparency, the many difficulties faced by life sciences innovators when applying for protection in the country are not addressed

14 January 2021

Three life sciences trade secrets and data strategy lessons

As non-patent assets become increasingly important, pharma and biotech innovators must adapt their IP strategies.

22 December 2020

Patent data shows the complexity of the semiconductor manufacturing market

There is no clear stand-out in what is a highly interconnected industry. Instead a host of companies all rank as innovation leaders

18 December 2020

What you need to know about post-Brexit changes to the UK’s SPC system

Failures to update IP management following the New Year could be costly for life sciences businesses

17 December 2020

Five key insights into 2020’s drug royalty transactions

It has been a year of creative and flexible deal-making with many life sciences entities taking advantage of the revenues this kind of IP monetisation can deliver

16 December 2020

East Asian giants leave their stamp on the IP market

IAM reveals the Asia IP Elite members for 2020 from two dynamic high-tech jurisdictions: South Korea and Taiwan

15 December 2020

The Asia IP Elite – a shared commitment to excellence across very different markets

IAM reveals the top in-house IP teams from India, Southeast Asia and Australasia

14 December 2020

Korea’s tough selection patent inventiveness rules may be overturned

The country’s Supreme Court is expected to hand down a potentially momentous decision in the coming months

10 December 2020

China’s gene sequencing equipment champion seeks public listing amidst sprawling global patent battle

BGI and its sequencer-manufacturing subsidiary MGI Tech made over 70% of their revenue abroad last year, but face over 20 patent assertions in overseas markets

10 December 2020

Unlock unlimited access to all IAM content